Discovery of Xuebijing Injection Exhibiting Protective Efficacy on Sepsis by Inhibiting the Expression of HMGB1 in Septic Rat Model Designed by Cecal Ligation and Puncture

被引:26
作者
Chen, Shengguang [1 ]
Dai, Guoxing [1 ]
Hu, Jiawen [1 ]
Rong, Aihong [1 ]
Lv, Jie [1 ]
Su, Lijie [1 ]
Wu, Xianzheng [1 ]
机构
[1] Tongji Univ, Tongji Hosp Affiliated, Dept Emergency, 389 Xin Cun Rd, Shanghai 200333, Peoples R China
关键词
XBJ; sepsis; HMGB1; CLP; TNF-; GENE-EXPRESSION; PATHOGENESIS; RELEASE;
D O I
10.1097/MJT.0000000000000296
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Xuebijing (XBJ) injection is a complex traditional Chinese prescription that has been widely used to treat sepsis in China. However, its underlying mechanisms on sepsis still remain uninvestigated. In this study, 150 male Sprague Dawley rats were randomly divided into a normal control group, cecal ligation and puncture (CLP) group, CLP+XBJ group, and CLP+gibberellic acid group. Each of them contained 3 subgroups of different treatment periods (12, 24, and 48 hours after injection, respectively). The mRNA expression of HMGB1 in liver tissue of the 4 groups was calculated by the semiquantitative reverse-transcription polymerase chain reaction. The level of IL-6, IL-10, and TNF- was determined by an enzyme-linked immunosorbent assay. Immunohistochemical analysis for HMGB1 showed the effect of XBJ on infiltration of inflammatory cells. The mRNA expression of HMGB1 in liver tissue in CLP+XBJ and CLP+gibberellic acid groups was lower than that in the CLP group. The levels of IL-6, IL-10, and TNF- were decreased at the each monitored time point. All these results indicated that XBJ exhibits protective efficacy on sepsis by inhibiting the expression of HMGB1.
引用
收藏
页码:E1819 / E1825
页数:7
相关论文
共 31 条
[1]  
Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084
[2]   Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis [J].
Angus, Derek C. ;
Yang, LiHong ;
Kong, Lan ;
Kellum, John A. ;
Delude, Russell L. ;
Tracey, Kevin J. ;
Weissfeld, Lisa .
CRITICAL CARE MEDICINE, 2007, 35 (04) :1061-1067
[3]  
Bie L, 2004, J MED POSTGRADUATES, V8
[4]   Blood interleukin 10 levels parallel the severity of septic shock [J].
Friedman, G ;
Jankowski, S ;
Marchant, A ;
Goldman, M ;
Kahn, RJ ;
Vincent, JL .
JOURNAL OF CRITICAL CARE, 1997, 12 (04) :183-187
[5]   High-mobility group box 1 protein plasma concentrations during septic shock [J].
Gibot, Sebastien ;
Massin, Frederic ;
Cravoisy, Aurelie ;
Barraud, Damien ;
Nace, Lionel ;
Levy, Brune ;
Bollaert, Pierre-Edouard .
INTENSIVE CARE MEDICINE, 2007, 33 (08) :1347-1353
[6]   Xuebijing Protects Rats from Sepsis Challenged with Acinetobacter baumannii by Promoting Annexin A1 Expression and Inhibiting Proinflammatory Cytokines Secretion [J].
He, Xian-Di ;
Wang, Yan ;
Wu, Qiong ;
Wang, Hua-Xue ;
Chen, Zhen-Dong ;
Zheng, Rong-Sheng ;
Wang, Zi-Shu ;
Wang, Jun-Bin ;
Yang, Yan .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
[7]  
He Xian-di, 2013, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V25, P537, DOI 10.3760/cma.j.issn.2095-4352.2013.09.007
[8]   Effect of Hemoperfusion Using Polymyxin B-Immobilized Fibers on Non-Shock Rat Sepsis Model [J].
Iba, Toshiaki ;
Okamoto, Kohei ;
Kawasaki, Shiori ;
Nakarai, Etsuro ;
Miyasho, Taku .
JOURNAL OF SURGICAL RESEARCH, 2011, 171 (02) :755-761
[9]   Incidence, Pathogenesis, and Management of Sepsis An Overview [J].
Kleinpell, Ruth M. ;
Graves, Brian T. ;
Ackerman, Michael H. .
AACN ADVANCED CRITICAL CARE, 2006, 17 (04) :385-393
[10]   Serum IL-1β, IL-6, IL-8, and TNF-α levels in early diagnosis and management of neonatal sepsis [J].
Kurt, A. Nese Citak ;
Aygun, A. Denizmen ;
Godekmerdan, Ahmet ;
Kurt, Abdullah ;
Dogan, Yasar ;
Yilmaz, Erdal .
MEDIATORS OF INFLAMMATION, 2007, 2007